Article
Where Does Morphology Fit in Myelodysplastic Syndrome Diagnosis in the Era of Molecular Testing?
Hematology/oncology clinics of North America - 1 Apr 2020
Giagounidis Aristoteles, Haase Sabine
Abstract excerpt
The recognition of cytologic dysplasia in blood and bone marrow remains the cornerstone of myelodysplastic syndromes (MDS) diagnosis because it distinguishes MDS from clonal hematopoiesis of indeterminate potential or clonal cytopenia of undetermined significance. Expert morphologists achieve high concordance in the diagnosis of MDS if appropriate clinical information is provided. Because of the low prevalence of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
